Education
About Us
Working with TipRanks
Follow Us
Lunai Bioworks, Inc. (LNAI)
:LNAI
LNAI Stock Chart & Stats
$1.20
--
Market closed
$1.20
--
Day’s Range― - ―
52-Week Range$0.13 - $21.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)600.18K
Market Cap
$27.82M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.24
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding23,180,246
10 Day Avg. Volume246,665
30 Day Avg. Volume600,181
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lunai Bioworks News
LNAI FAQ
What was Lunai Bioworks, Inc.’s price range in the past 12 months?
Lunai Bioworks, Inc. lowest stock price was $0.13 and its highest was $21.00 in the past 12 months.
What is Lunai Bioworks, Inc.’s market cap?
Lunai Bioworks, Inc.’s market cap is $27.82M.
When is Lunai Bioworks, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lunai Bioworks, Inc.’s earnings last quarter?
Currently, no data Available
Is Lunai Bioworks, Inc. overvalued?
According to Wall Street analysts Lunai Bioworks, Inc.’s price is currently Overvalued.
Does Lunai Bioworks, Inc. pay dividends?
Lunai Bioworks, Inc. does not currently pay dividends.
What is Lunai Bioworks, Inc.’s EPS estimate?
Lunai Bioworks, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lunai Bioworks, Inc. have?
Lunai Bioworks, Inc. has 23,180,246 shares outstanding.
What happened to Lunai Bioworks, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lunai Bioworks, Inc.?
Currently, no hedge funds are holding shares in LNAI
Company Description
Lunai Bioworks, Inc.
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
Technical Analysis
Daré Bioscience
―
Akari Therapeutics
―
Collplant Holdings
―
Iterum Therapeutics
―
Neurosense Therapeutics Ltd.
―